S100A16 drives hepatocellular carcinoma by promoting KCNJ8-mediated choline metabolic dysregulation and immunosuppression - Nature
1fuente
1país
1idioma
02:37detectada el 18/11 (08:37 UTC)
02:37última novedad, 18/11
1noticia
Cadena de publicación
La publicó primero Nature (Ghana) el 18/11 a las 02:37 (08:37 UTC).
-
02:3718/11, 08:37 UTC
NANature news.google.comS100A16 drives hepatocellular carcinoma by promoting KCNJ8-mediated choline metabolic dysregulation and immunosuppression - Nature
GH EN Primera
Datos de esta historia: JSON



